Beraza, Naiara

Publishing since 2002 (Junior)

Has published 14 publications in 9 years

Number of publications published per year by Beraza, Naiara. (Source : PubMed)

Distribution of publications types for Beraza, Naiara. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kroy DC, Beraza N, Tschaharganeh DF, Sander LE, Erschfeld S, Giebeler A, Liedtke C, Wasmuth HE, Trautwein C, Streetz KL. Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice.  Hepatology  2010;51;2  
•  Beraza N, Malato Y, Sander LE, Al-Masaoudi M, Freimuth J, Riethmacher D, Gores GJ, Roskams T, Liedtke C, Trautwein C. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.  J. Exp. Med.  2009;206;8  
•  Varela-Rey M, Fernández-Ramos D, Martínez-López N, Embade N, Gómez-Santos L, Beraza N, Vázquez-Chantada M, Rodríguez J, Luka Z, Wagner C, Lu SC, Martínez-Chantar ML, Mato JM. Impaired liver regeneration in mice lacking glycine N-methyltransferase.  Hepatology  2009;50;2  
•  Beraza N, Trautwein C. The gut-brain-liver axis: a new option to treat obesity and diabetes?  Hepatology  2008;48;3  
•  Malato Y, Sander LE, Liedtke C, Al-Masaoudi M, Tacke F, Trautwein C, Beraza N. Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration.  Hepatology  2008;47;6  
•  Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, de Vos R, Roskams T, Trautwein C. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.  Gut  2008;57;5  
•  Beraza N, Lüdde T, Assmus U, Roskams T, Vander Borght S, Trautwein C. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.  Gastroenterology  2007;132;7  
•  Beraza N, Trautwein C. Restoration of p53 function: a new therapeutic strategy to induce tumor regression?  Hepatology  2007;45;6  
•  Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, Roskams T, Trautwein C, Pasparakis M. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.  Cancer Cell  2007;11;2  
•  Luedde T, Beraza N, Trautwein C. Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal models.  J. Gastroenterol. Hepatol.  2006;21 Suppl 3  

[ See timeline ] [ See all publications ]